Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

CH7233163

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Roche

Drug class:

EGFR inhibitor

Related drugs:

‹

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

ABP 494 (cetuximab biosimilar) (1)

BAY 2927088 (1)

Compound 6a (1)

abivertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

›

EGFR L858R + EGFR T790M	Non Small Cell Lung Cancer	EGFR L858R + EGFR T790M	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR L858R	Non Small Cell Lung Cancer	EGFR L858R	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR exon 19 deletion + EGFR T790M	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR T790M	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR exon 19 deletion	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D